High lipoprotein(a): Actionable strategies for risk assessment and mitigation

• Main Authors: Gissette Reyes-Soffer (Author), Calvin Yeang (Author), Erin D Michos (Author), Wess Boatwright (Author), Christie M Ballantyne (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

High levels of lipoprotein(a) [Lp(a)] are causal for atherosclerotic cardiovascular disease (ASCVD). Lp(a) is the most prevalent inherited dyslipidemia and strongest genetic ASCVD risk factor. This risk persists in the presence of at target, guideline-recommended, LDL-C levels and adherence to lifes...